These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23458586)

  • 41. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004.
    Ostchega Y; Dillon CF; Hughes JP; Carroll M; Yoon S
    J Am Geriatr Soc; 2007 Jul; 55(7):1056-65. PubMed ID: 17608879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.
    Yano Y; Reis JP; Colangelo LA; Shimbo D; Viera AJ; Allen NB; Gidding SS; Bress AP; Greenland P; Muntner P; Lloyd-Jones DM
    JAMA; 2018 Nov; 320(17):1774-1782. PubMed ID: 30398601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society.
    Ramsay L; Williams B; Johnston G; MacGregor G; Poston L; Potter J; Poulter N; Russell G
    J Hum Hypertens; 1999 Sep; 13(9):569-92. PubMed ID: 10482967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Herbal or Dietary Supplement Use and Hypertensive Medications: Does the Combination Relate to Medication Adherence and Blood Pressure Control?
    Nagawa CS; Palakshappa JA; Sadasivam RS; Houston TK
    J Altern Complement Med; 2021 Feb; 27(2):168-175. PubMed ID: 33296255
    [No Abstract]   [Full Text] [Related]  

  • 46. Prevalence of Hypertension, Treatment, and Blood Pressure Targets in Canada Associated With the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines.
    Garies S; Hao S; McBrien K; Williamson T; Peng M; Khan NA; Padwal RS; Quan H; Leung AA;
    JAMA Netw Open; 2019 Mar; 2(3):e190406. PubMed ID: 30848811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity.
    Parikh JS; Randhawa AK; Wharton S; Edgell H; Kuk JL
    J Obes; 2018; 2018():4573258. PubMed ID: 30364090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.
    Lloyd-Jones DM; Evans JC; Larson MG; O'Donnell CJ; Roccella EJ; Levy D
    Hypertension; 2000 Oct; 36(4):594-9. PubMed ID: 11040241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
    Khera R; Lu Y; Lu J; Saxena A; Nasir K; Jiang L; Krumholz HM
    BMJ; 2018 Jul; 362():k2357. PubMed ID: 29997129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.
    Burt VL; Cutler JA; Higgins M; Horan MJ; Labarthe D; Whelton P; Brown C; Roccella EJ
    Hypertension; 1995 Jul; 26(1):60-9. PubMed ID: 7607734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guideline on Contemporary Practice: A Cross-Sectional Analysis From NCDR PINNACLE Registry.
    Hussain A; Virani SS; Zheng L; Gluckman TJ; Borden WB; Masoudi FA; Maddox TM
    J Am Heart Assoc; 2022 Jun; 11(11):e024107. PubMed ID: 35656989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood pressure control in treated hypertensive Middle Eastern patients: a post hoc analysis based on JNC8 definitions.
    Alhaddad IA; Hamoui O; Hammoudeh A; Mallat S
    Vasc Health Risk Manag; 2019; 15():35-46. PubMed ID: 30881006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    BMC Fam Pract; 2013 Jun; 14():88. PubMed ID: 23800117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors associated with therapeutic goal attainment in patients with concomitant hypertension and dyslipidemia.
    Chopra I; Kamal KM
    Hosp Pract (1995); 2014 Apr; 42(2):77-88. PubMed ID: 24769787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting Out-of-Office Blood Pressure in a Diverse US Population.
    Bellows BK; Xu J; Sheppard JP; Schwartz JE; Shimbo D; Muntner P; McManus RJ; Moran AE; Bryant KB; Cohen LP; Bress AP; King JB; Shikany JM; Green BB; Yano Y; Clark D; Zhang Y
    Am J Hypertens; 2022 Jun; 35(6):533-542. PubMed ID: 35040867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.
    Hajjar I; Kotchen TA
    JAMA; 2003 Jul; 290(2):199-206. PubMed ID: 12851274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporation of Biomarkers Into Risk Assessment for Allocation of Antihypertensive Medication According to the 2017 ACC/AHA High Blood Pressure Guideline: A Pooled Cohort Analysis.
    Pandey A; Patel KV; Vongpatanasin W; Ayers C; Berry JD; Mentz RJ; Blaha MJ; McEvoy JW; Muntner P; Vaduganathan M; Correa A; Butler J; Shimbo D; Nambi V; deFilippi C; Seliger SL; Ballantyne CM; Selvin E; de Lemos JA; Joshi PH
    Circulation; 2019 Dec; 140(25):2076-2088. PubMed ID: 31707797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health insurance status and hypertension monitoring and control in the United States.
    Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
    Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk.
    Colantonio LD; Booth JN; Bress AP; Whelton PK; Shimbo D; Levitan EB; Howard G; Safford MM; Muntner P
    J Am Coll Cardiol; 2018 Sep; 72(11):1187-1197. PubMed ID: 30189994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.